Leucine

CAS 61-90-5 10 current records 6 historicalSmall Molecule

Who holds supplier records for Leucine? 10 organisations hold a current record for Leucine: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (4), Japan (2), Germany (1) and United States (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Leucine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/leucine

Reading the evidence

  • 10 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (10)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Leucine. Country is the organisation's recorded country, not necessarily the manufacturing site.

China4Japan2Germany1United States1Country not recorded for 2
Need Leucine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (7)

Certificates of Suitability on the EDQM register for Leucine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 14 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
EVONIK REXIM (NANNING) PHARMACEUTICAL CO., LTD. NanningCN
CEP 2025-632 - Rev 01
Leucine, Process 2
Oct 2026—
AJINOMOTO CO., INC. Chuo-KuJP
CEP 2008-233 - Rev 02
Leucine
Aug 2026—
SHANGHAI PLUMINO AMINO ACID CO., LTD. ShanghaiCN
CEP 2010-189 - Rev 01
Leucine
Oct 2025Inspected Mar 2024
Germany
YICHANG SANXIA PROUDIN BIOPHARMACEUTICAL CO., LTD. YichangCN
CEP 2023-459 - Rev 00
Leucine
Jun 2024—
TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. TianjinCN
R0-CEP 2020-207 - Rev 00
Leucine
Oct 2022—
AMINO GMBH FrellstedtDE
R1-CEP 2014-156 - Rev 00
Leucine, Obtained from fermentation
Dec 2021—
KYOWA HAKKO BIO CO., LTD. TokyoJP
R1-CEP 1999-160 - Rev 03
Leucine
Aug 2013—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (6)

Organisations whose Type II DMFs for Leucine are no longer active. These show a past filing, not current supply.

Show all 6 historical records
  • YONEYAMA YAKUHIN KOGYO CO LTD
    Inactive DMF 9488 · filed Jan 1992
  • Japan · Inactive DMF 7223 · filed Oct 1987
  • DEGUSSA AG WERK RADEBEUL
    Inactive DMF 4009 · filed Nov 1980
  • SIGMA F AND D DIV LTD
    Inactive DMF 2778 · filed Oct 1976
  • KYOWA HAKKO USA INC
    Inactive DMF 2622 · filed Feb 1976
  • TANABE SEIYAKU CO LTD
    Inactive DMF 1275 · filed Dec 1968

Overview

Leucine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL291962).

Chemical identity

IUPAC name
(2S)-2-amino-4-methylpentanoic acid
Canonical SMILES
CC(C)C[C@@H](C(=O)O)N
InChIKey
ROHFNLRQFUQHCH-YFKPBYRVSA-N
Synonyms
E641, FEMA NO. 3297, Leucina, Leucine, Leucine, l, L-leucine, NSC-46709, (S)-Leucine, (S)-2-Amino-4-methylpentanoic acid, (2S)-2-amino-4-methylpentanoic acid, Leucin, (S)-2-Amino-4-methylvaleric acid

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Leucine?

10 organisations hold an active US FDA Type II Drug Master File or a CEP for Leucine: AMINO GMBH (Germany), AJINOMOTO HEALTH AND NUTRITION NORTH AMERICA INC (United States), MIANYANG SHENGSHI HEALTH TECHNOLOGY CO LTD, SHANGHAI AJINOMOTO AMINO ACID CO LTD (China), AJINOMOTO CO INC (Japan), EVONIK REXIM NANNING PHARMACEUTICAL CO LTD, Kyowa Hakko Bio Co., Ltd. (Japan) and Shanghai Plumino Amino Acid Co.,Ltd. (China), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Leucine Drug Master Files are active?

AMINO GMBH (DMF 3828), AJINOMOTO HEALTH AND NUTRITION NORTH AMERICA INC (DMF 31556), MIANYANG SHENGSHI HEALTH TECHNOLOGY CO LTD (DMF 43269) and SHANGHAI AJINOMOTO AMINO ACID CO LTD (DMF 21593, 21761). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Leucine records mean?

6 organisations have only inactive Type II DMFs for Leucine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Leucine have a European Certificate of Suitability?

Yes. 7 organisations hold a valid CEP for Leucine on the EDQM register, including EVONIK REXIM (NANNING) PHARMACEUTICAL CO., LTD. Nanning (CN), AJINOMOTO CO., INC. Chuo-Ku (JP), SHANGHAI PLUMINO AMINO ACID CO., LTD. Shanghai (CN), YICHANG SANXIA PROUDIN BIOPHARMACEUTICAL CO., LTD. Yichang (CN), TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. Tianjin (CN) and AMINO GMBH Frellstedt (DE) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Leucine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Leucine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.